R&D and Testing of New Radiopharmaceuticals

Address: ÚJV Řež, a. s., Hlavní 130, 250 68 Husinec - Řež

• The PET Center serves primarily for the R&D of new radiopharmaceuticals with ultra-short-living PET radionuclides.The workplace also includes the production of radiopharmaceuticals registered by ÚJV Řež, a. s.
• This project was awarded third place in the category of “Investor of 2010”.
  The prize for the highest innovation potential was awarded by CzechInvest in cooperation with the Ministry of Industry and Trade and the Association for Foreign Investment. The project was co-financed from the European Regional Development Fund (ERDF) and from the national budget of the Czech Republic under the POTENTIAL programme. The construction of a third floor of the R&D PET Centre Řež followed which, in cooperation with the health facility, plays a development-manufacturing-application role. The implementation of the second phase of the PET centre was supported by the European Regional Development Fund (ERDF) and the national budget of the Czech Republic under the OPPI programme (Operational Programme Enterprise and Innovation – Ministry of Industry and Trade), the Training Centre programme

• We are holders of all necessary permits and certificates
• We have adequate spatial and technological facilities and experienced highly educated staff.

The defined and set chemical and physical control processes in the GMP mode cover areas of PET radiopharmaceuticals as well as other pharmaceutical raw substances and materials. Quality control with appropriate instrumentation includes

:

• Input raw materials
• Intermediate products
• Medicinal products
• Microbiological control
• Monitoring stability
• Validation of analytical methods